MedTech & Diagnostics
Integer Holdings Executive Compensation (FY25)
ITGR · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 22, 2026
249 figures on this page: 238 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
Payman Khales, President and Chief Executive Officer, received $3,211,860 in total compensation for fiscal 2025, and Khales' total was 62.5% higher than the $1,976,810 reported for fiscal 2024. Separately, the disclosed chief executive pay ratio for fiscal 2025 is 86:1, against median employee compensation of $44,550. For fiscal 2025, the say-on-pay proposal drew 98.7% support at the meeting held May 22, 2026, and companies named in the disclosed peer group include Avanos Medical, Inc., Benchmark Electronics, Inc., Bruker Corporation, CONMED Corporation and Enovis Corporation, among others.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Payman Khales: $1,976,810 → $3,211,860 (62.5% higher)
CEO pay ratio: 238:1 → 86:1 (63.9% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Integer Holdings' chief executive and what were they paid?
Payman Khales, President and Chief Executive Officer, received $3,211,860 in total compensation for fiscal 2025. Khales' total was 62.5% higher than the $1,976,810 reported for fiscal 2024.
What was Integer Holdings' say-on-pay result?
For fiscal 2025, the say-on-pay proposal drew 98.7% support at the meeting held May 22, 2026.
Which companies are in Integer Holdings' peer group?
Companies named in the disclosed peer group include Avanos Medical, Inc., Benchmark Electronics, Inc., Bruker Corporation, CONMED Corporation and Enovis Corporation, among others.
What is Integer Holdings' chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 86:1, against median employee compensation of $44,550.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Dziedzic Former President and CEO | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Payman Khales President and CEO | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Diron Smith Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Dziedzic Former President and CEO | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Diron Smith Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Payman Khales President and CEO | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jim Stephens President, Cardiac Rhythm Management & Neuromodulation | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Dziedzic Former President and Chief Executive Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Payman Khales President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Diron Smith Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Andrew Senn President, Cardio & Vascular | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Jim Stephens President, Cardiac Rhythm Management & Neuromodulation | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Lindsay Blackwood Senior Vice President, General Counsel and Corporate Secretary | ◇ | ◇ | ◇ | — | ◇ | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Diron Smith | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Payman Khales | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Payman Khales | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Payman Khales | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Payman Khales | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Lindsay Blackwood | RSU | ◇ | ◇ | — | — |
| Andrew Senn | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Payman Khales | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Joseph Dziedzic | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Diron Smith | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Jim Stephens | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Pamela G. Bailey Board chair | ◇ | ◇ | — | — | — | — | ◇ |
James F. Hinrichs | ◇ | ◇ | — | — | — | — | ◇ |
Donald J. Spence | ◇ | ◇ | — | — | — | — | ◇ |
M. Craig Maxwell | ◇ | ◇ | — | — | — | — | ◇ |
Alvin (Tyrone) Jeffers | ◇ | ◇ | — | — | — | — | ◇ |
Sheila Antrum | ◇ | ◇ | — | — | — | — | ◇ |
Jean Hobby | ◇ | ◇ | — | — | — | — | ◇ |
Filippo Passerini | ◇ | ◇ | — | — | — | — | ◇ |
Cheryl C. Capps | ◇ | ◇ | — | — | — | — | ◇ |
Michael J. Coyle | ◇ | ◇ | — | — | — | — | ◇ |
William B. Summers, Jr | ◇ | — | — | — | — | — | ◇ |
James F. Flanagan, Joseph W. Dziedzic, Aaron Kapito and Payman Khales served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Avanos Medical, Inc. AVNS
- Benchmark Electronics, Inc. BHE
- Bruker Corporation BRKR
- CONMED Corporation CNMD
- Enovis Corporation ENOV
- Envista Holdings Corporation NVST
- Globus Medical, Inc. GMED
- Haemonetics Corporation HAE
- ICU Medical, Inc. ICUI
- Integra LifeSciences Holdings Corporation IART
- LivaNova PLC LIVN
- Masimo Corporation MASI
- Merit Medical Systems, Inc. MMSI
- Methode Electronics, Inc. MEI
- Nordson Corporation NDSN
- Orthofix Medical Inc. OFIX
- OSI Systems, Inc. OSIS
- Plexus Corp. PLXS
- Teleflex Incorporated TFX
- Varex Imaging Corporation VREX
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 22, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 21, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 22, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 24, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 18, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 19, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 20, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 22, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 22, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 23, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | May 24, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Integer Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Integer Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
249 figures on this page: 238 cited to the filing that reported them, 11 calculated from figures it prints.
238 cited to the filing
11 calculated from the filing
Documents cited
- 0001114483-26-000021Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-26-000009CEO Pay Ratio · Director Compensation · Grants of Plan-Based Awards · Outstanding Equity Awards at 2025 Fiscal Year-End · and 1 more section
- 0001114483-25-000116Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-25-0000752024 Summary Compensation Table
- 0001114483-24-000086Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-24-0000532023 Summary Compensation Table
- 0001114483-23-000022Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-22-000018Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-21-000016Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001114483-20-000009
- 0001114483-19-000013
- 0001628280-18-007155
- 0001114483-17-000011
- 0001114483-16-000026Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Integer Holdings executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ITGR (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Integer Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Integer Holdings discloses
The companies named in ITGR's own disclosed peer group.
Avanos Medical, Inc.Benchmark Electronics, Inc.Bruker CorporationCONMED CorporationEnovis CorporationEnvista Holdings CorporationGlobus Medical, Inc.Haemonetics CorporationICU Medical, Inc.Integra LifeSciences Holdings CorporationLivaNova PLCMasimo CorporationMerit Medical Systems, Inc.Orthofix Medical Inc.OSI Systems, Inc.Plexus Corp.Teleflex Incorporated
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}